Evaluation of infectious complications of the implantable venous access system in a general oncologic population

American Journal of Infection Control

Volumn 31, Issue 1, 2003, Pages 34-39

  Chang, Lilu ^a,b   Tsai, Jir Shiong ^a   Huang, Shin Ju ^a   Shih, Chiang Ching ^a  

^a KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

^b NONE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD FLOW; CANCER PATIENT; CANDIDA; CATHETER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; IMPLANTABLE PORT SYSTEM; INFECTION RATE; INFECTIOUS COMPLICATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; TOTAL PARENTERAL NUTRITION; VENOUS CIRCULATION;

EID: 0037320249     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1067/mic.2003.29     Document Type: Article

References (21)

1. Lambert ME, Chadwick GA, McMahon A, Scarffe JH. Experience with the Port-a-Cath. Hematol Oncol 1988;6:57-63.
2. May GS, Davis C. Percutaneous catheters and totally implantable access systems: a review of reported infection rates. J Intravenous Nurs 1988;11(2):97-103.
3. Strum B, McDermed J, Korn A, Joseph C. Improved methods for venous access: the Port-a-Cath, a totally implanted catheter system. J Clin Oncol 1986;4(4):596-603.
4. Carde P, Cosset-Delaigue MF, Laplanche A, Chareau I. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol 1989;25:939-44.
5. Barrios CH, Zuke JE, Blaes B, Hirsch JD, Lyss AP. Evaluation of an implantable venous access system in a general oncology population. Oncology 1992;49:474-8.
6. Sinoff CL, Koski T. Port-a-Cath in cancer patients. S Afr Med J 1993;83:412-6.
7. Wesenberg F, Ftaatten H, Janssen CW. Central venous catheter with subcutaneous injection port (Port-a-Cath): 8 years clinical follow up with children. Pediatr Hematol Oncol 1993;10:233-9.
8. Poorter RL, Lauw FN, Bemelman WA, Bakker PJM, Taat CW, Veenhof CHN. Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy. Eur J Cancer 1996;32A:2262-66.
9. Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW. Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg 1998;22:12-6.
10. Schwarz RE, Groeger JS, Coit DG. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer 1997;79:1635-40.
11. Ballarini C, Intra M, Pisani Ceretti A, Cordovana A, Pagani M, Farina G, et al. Complications of subcutaneous infusion port in the general oncology population. Oncology 1999;56:97-102.
12. Torramade JR, Cienfuegos JA, Hernandez JL, Pardo F, Benito C, Gonzalez J. The complications of central venous access systems: a study of 218 patients. Eur J Surg 1993;159:323-7.
13. Raad I, Hanna H. Nosocomial infections related to use of intravascular devices inserted for long-term vascular access. In: Mayhall CG, ed. Hospital epidemiology and infection control. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1999. p. 165-72.
14. Hempsey SJ,Young JE, Alcock SR, Stack BH. Needle change preferences and rate of infection in cystic fibrosis adult with a Port-a-Cath device in situ [abstract]. Thorax 1998;53(Suppl4):A62
15. Centers for Disease Control and Prevention, Department of Health and Human Services. Draft guideline for prevention of intravascular device-related infection. Federal Register 1994;60:49,978-50,006.
16. Maki DG. Infections causes by intravascular devices used for infusion therapy: pathogenesis, prevention and management In: Bisno A, Waldvogel FA, eds. Infections associated with indwelling medical devices. 2nd ed. Washington (DC):ASM Press; 1994. p. 155-212.
17. Wheat LJ. Fungal infections in the immunocompromised host. In: Rubin RH, Young LS, eds. Clinical approach to infection in the compromised host 3rd ed. New York: Plenum Medical Book Company; 1994. p. 211-32.
18. Borzotta AP, Beardsley K. Candida infections in critically ill trauma patients: a retrospective case-control study. Arch Surg 1999;134:657-64.
19. Chiu NC, Chung YF, Huang FY. Pediatric nosocomial fungal infections. Southeast Asian J Trop Med Public Health 1997;28(1):191-5.
20. Dean DA, Burchard KW. Fungal infection in surgical patients. Am J Surg 1996;171:374-82.
21. Flynn PM, Marina NM, Rivera GK, Hughes WT. Candida tropicalis infections in children with leukemia. Leuk Lymphoma 1993;10:369-76.